Healthscope Limited
(ASX:HSO) has inked a deal to sell its local Australian pathology operations to Crescent Capital Partners for $105 million to focus on its core hospitals business.
The private hospital operator says these operations consist of about 550 collection centres and 31 laboratories in Victoria, South Australia, New South Wales and the Northern Territory.
CEO Robert Cooke says the operations are non-core and have been operating in challenging market conditions while making a limited underlying earnings contribution.
Mr Cooke has also affirmed Healthscope remains committed to its International Pathology operations which have consistently performed well over time.
Healthscope reported a net profit of $58.56 million in the first half of the 2015 financial year.
